These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 37219917)
21. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect. Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017 [TBL] [Abstract][Full Text] [Related]
22. A GSH-Responsive Nanoprodrug System Based on Self-Assembly of Lactose Modified Camptothecin for Targeted Drug Delivery and Combination Chemotherapy. Hou C; Ma N; Shen Z; Chi G; Chao S; Pei Y; Chen L; Lu Y; Pei Z Int J Nanomedicine; 2020; 15():10417-10424. PubMed ID: 33376329 [TBL] [Abstract][Full Text] [Related]
23. Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance. Cui H; Huan ML; Ye WL; Liu DZ; Teng ZH; Mei QB; Zhou SY Mol Pharm; 2017 Mar; 14(3):746-756. PubMed ID: 28146635 [TBL] [Abstract][Full Text] [Related]
24. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery. Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750 [TBL] [Abstract][Full Text] [Related]
25. Preparation of polyethylene glycol-polyacrylic acid block copolymer micelles with pH/hypoxic dual-responsive for tumor chemoradiotherapy. Weng J; Huang Z; Pu X; Chen X; Yin G; Tian Y; Song Y Colloids Surf B Biointerfaces; 2020 Jul; 191():110943. PubMed ID: 32203861 [TBL] [Abstract][Full Text] [Related]
26. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy. Gao D; Lo PC J Control Release; 2018 Jul; 282():46-61. PubMed ID: 29673646 [TBL] [Abstract][Full Text] [Related]
27. Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance. Qiu L; Xu J; Ahmed KS; Zhu M; Zhang Y; Long M; Chen W; Fang W; Zhang H; Chen J Acta Biomater; 2022 Mar; 140():686-699. PubMed ID: 34875359 [TBL] [Abstract][Full Text] [Related]
28. pH and GSH dual-responsive drug-controlled nanomicelles for breast cancer treatment. Xu J; Tang X; Yang X; Zhao MX Biomed Mater; 2023 Feb; 18(2):. PubMed ID: 36720160 [TBL] [Abstract][Full Text] [Related]
29. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin. Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505 [TBL] [Abstract][Full Text] [Related]
30. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy. He W; Du Y; Zhou W; Wang T; Li M; Li X Eur J Pharm Sci; 2020 Jul; 150():105340. PubMed ID: 32371069 [TBL] [Abstract][Full Text] [Related]
31. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release. Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663 [TBL] [Abstract][Full Text] [Related]
32. pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells. Gao Y; Jia L; Wang Q; Hu H; Zhao X; Chen D; Qiao M ACS Appl Mater Interfaces; 2019 May; 11(18):16296-16310. PubMed ID: 30997984 [TBL] [Abstract][Full Text] [Related]
33. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation. Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165 [TBL] [Abstract][Full Text] [Related]
34. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy. Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873 [TBL] [Abstract][Full Text] [Related]
35. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552 [TBL] [Abstract][Full Text] [Related]
36. Folate-decorated PEGylated triblock copolymer as a pH/reduction dual-responsive nanovehicle for targeted intracellular co-delivery of doxorubicin and Bcl-2 siRNA. Suo A; Qian J; Xu M; Xu W; Zhang Y; Yao Y Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():659-672. PubMed ID: 28482576 [TBL] [Abstract][Full Text] [Related]
37. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice. Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307 [TBL] [Abstract][Full Text] [Related]
38. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions. Wu L; Zou Y; Deng C; Cheng R; Meng F; Zhong Z Biomaterials; 2013 Jul; 34(21):5262-72. PubMed ID: 23570719 [TBL] [Abstract][Full Text] [Related]
39. Preparation of multilocation reduction-sensitive core crosslinked folate-PEG-coated micelles for rapid release of doxorubicin and tariquidar to overcome drug resistance. Yi X; Zhao D; Zhang Q; Xu J; Yuan G; Zhuo R; Li F Nanotechnology; 2017 Feb; 28(8):085603. PubMed ID: 28055982 [TBL] [Abstract][Full Text] [Related]
40. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]